In the following research, they found that lupeol can down-regulate CD133 expression and sensitize HCC cells to chemotherapeutic agents through the phosphatase and tensin homolog (PTEN)–Akt–ABCG2 pathway [38]. The gene discussed is PTEN; the disease is hepatocellular carcinoma.